ACN(ACN)
ACN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $73.62B | $76.58B | $80.60B | $89.76B | $97.61B |
| Low | $73.46B | $75.69B | $80.50B | $88.93B | $96.71B |
| High | $73.80B | $77.86B | $80.71B | $91.12B | $99.09B |
| EBITDA Avg | $12.83B | $13.35B | $14.05B | $15.65B | $17.02B |
| Low | $12.80B | $13.19B | $14.03B | $15.50B | $16.86B |
| High | $12.86B | $13.57B | $14.07B | $15.88B | $17.27B |
| EBIT Avg | $11.03B | $11.48B | $12.08B | $13.45B | $14.63B |
| Low | $11.01B | $11.34B | $12.06B | $13.32B | $14.49B |
| High | $11.06B | $11.67B | $12.09B | $13.65B | $14.85B |
| Net Income Avg | $8.74B | $9.01B | $9.72B | $11.66B | $11.97B |
| Low | $8.69B | $8.85B | $9.23B | $11.52B | $11.82B |
| High | $8.80B | $9.47B | $10.52B | $11.89B | $12.20B |
| EPS Avg | $13.86 | $14.66 | $15.72 | $18.44 | $18.92 |
| Low | $13.74 | $13.99 | $14.59 | $18.22 | $18.69 |
| High | $13.91 | $14.97 | $16.63 | $18.80 | $19.29 |
| Analysts (Rev / EPS) | 18 / 16 | 21 / 18 | 18 / 11 | 9 / 4 | 17 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $18.05B | $19.42B | $18.70B | $19.51B | $18.95B | $20.58B | $19.83B | $20.68B |
| Low | $17.94B | $19.07B | $18.42B | $19.22B | $18.66B | $20.27B | $19.53B | $20.37B |
| High | $18.16B | $19.54B | $18.86B | $19.68B | $19.11B | $20.76B | $20.01B | $20.86B |
| EBITDA Avg | $3.15B | $3.38B | $3.26B | $3.40B | $3.30B | $3.59B | $3.46B | $3.60B |
| Low | $3.13B | $3.32B | $3.21B | $3.35B | $3.25B | $3.53B | $3.41B | $3.55B |
| High | $3.17B | $3.41B | $3.29B | $3.43B | $3.33B | $3.62B | $3.49B | $3.64B |
| EBIT Avg | $2.71B | $2.91B | $2.80B | $2.92B | $2.84B | $3.08B | $2.97B | $3.10B |
| Low | $2.69B | $2.86B | $2.76B | $2.88B | $2.80B | $3.04B | $2.93B | $3.05B |
| High | $2.72B | $2.93B | $2.83B | $2.95B | $2.86B | $3.11B | $3.00B | $3.13B |
| Net Income Avg | $1.96B | $2.46B | $1.95B | $2.47B | $2.14B | $2.64B | $2.18B | $2.72B |
| Low | $1.93B | $2.37B | $1.91B | $2.42B | $2.10B | $2.59B | $2.14B | $2.66B |
| High | $2.04B | $2.56B | $1.97B | $2.50B | $2.17B | $2.67B | $2.20B | $2.75B |
| EPS Avg | $3.18 | $3.99 | $3.16 | $4.01 | $3.48 | $4.28 | $3.54 | $4.42 |
| Low | $3.14 | $3.85 | $3.10 | $3.93 | $3.41 | $4.20 | $3.47 | $4.33 |
| High | $3.31 | $4.15 | $3.20 | $4.06 | $3.52 | $4.33 | $3.58 | $4.47 |
| Analysts (Rev / EPS) | 12 / 14 | 11 / 13 | 5 / 5 | 6 / 7 | 9 / 8 | 5 / 8 | 4 / 8 | 6 / 11 |